From: Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
Variable | Value | Total N | Column % | Cancer N | Row % | OR | LCL | UCL | P |
---|---|---|---|---|---|---|---|---|---|
Age | 18–54 | 145 | 40.1 | 4 | 2.8 | 0.07 | 0.02 | 0.23 | < 0.0001 |
Age | 55–64 | 108 | 29.8 | 12 | 11.1 | 0.31 | 0.13 | 0.74 | 0.009 |
Age | 65–74 | 64 | 17.7 | 17 | 26.6 | 0.89 | 0.38 | 2.08 | 0.79 |
Age | 75 + | 45 | 12.4 | 13 | 28.9 | 1.00 | |||
Sex | Female | 90 | 24.9 | 11 | 12.2 | 0.94 | 0.46 | 1.94 | 0.86 |
Sex | Male | 271 | 75.1 | 35 | 12.9 | 1.00 | |||
Race | White | 101 | 27.9 | 31 | 30.7 | 7.26 | 3.71 | 14.21 | < 0.0001 |
Race | Other | 261 | 72.1 | 15 | 5.7 | 1.00 | |||
MMP9 (pg/mL) | < 4,681.7 | 351 | 98.3 | 41 | 11.7 | 1.00 | |||
M | ≥ 4,681.7 | 6 | 1.7 | 5 | 83.3 | 37.80 | 4.31 | 331.63 | 0.001 |
CXCL8/IL8 (pg/mL) | < 3,166.3 | 355 | 98.3 | 42 | 11.8 | 1.00 | |||
≥ 3,166.3 | 6 | 1.7 | 4 | 66.7 | 14.90 | 2.65 | 83.87 | 0.002 | |
VEGFA (pg/mL) | < 1,837.5 | 350 | 98.3 | 41 | 11.7 | 1.00 | |||
≥ 1,837.5 | 6 | 1.7 | 5 | 83.3 | 37.68 | 4.30 | 330.57 | 0.001 | |
IX/CA9 (pg/mL) | < 22.429 | 351 | 97.5 | 38 | 10.8 | 1.00 | |||
≥ 22.429 | 9 | 2.5 | 8 | 88.9 | 65.89 | 8.02 | 541.31 | 0.0001 | |
SDC1 (pg/mL) | < 70,803 | 357 | 100.0 | 46 | 12.9 | 1.00 | |||
≥ 70,803 | 0 | 0.0 | |||||||
PAI1 (pg/mL) | < 643.76 | 343 | 95.5 | 33 | 9.6 | 1.00 | |||
≥ 643.76 | 16 | 4.5 | 12 | 75.0 | 28.18 | 8.60 | 92.37 | < 0.0001 | |
ApoE (pg/mL) | < 9,433.5 | 339 | 95.0 | 31 | 9.1 | 1.00 | |||
≥ 9,433.5 | 18 | 5.0 | 15 | 83.3 | 49.68 | 13.63 | 181.09 | < 0.0001 | |
A1AT (pg/mL) | < 337,795 | 343 | 96.6 | 37 | 10.8 | 1.00 | |||
≥ 337,795 | 12 | 3.4 | 9 | 75.0 | 24.81 | 6.43 | 95.75 | <0 .0001 | |
ANG (pg/mL) | < 1,951.8 | 339 | 95.2 | 34 | 10.0 | 1.00 | |||
≥ 1,951.8 | 17 | 4.8 | 11 | 64.7 | 16.44 | 5.72 | 47.27 | <0 .0001 | |
MM10 (pg/mL) | < 40.975 | 347 | 97.2 | 38 | 11.0 | 1.00 | |||
≥ 40.975 | 10 | 2.8 | 7 | 70.0 | 18.97 | 4.71 | 76.46 | < 0.0001 |